Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes
about
Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile diseaseFirst international external quality assessment study on molecular and serological methods for yellow fever diagnosisVirus-like particles production in green plantsUtility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In VitroA high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopesLethal antibody enhancement of dengue disease in mice is prevented by Fc modificationComparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibodyCryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic SitesRecent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and PathogenesisCrystal Structure of the West Nile Virus Envelope GlycoproteinAntibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinDifferentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-ReactivityPediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusInduction of Epitope-Specific Neutralizing Antibodies against West Nile VirusType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesMonoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and VaccinesMaturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated NeutralizationEnzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus InfectionsAntibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain IIDifferential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion PropertiesClosing the door on flaviviruses: Entry as a target for antiviral drug designThe structural immunology of antibody protection against West Nile virusHumoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle AntigensMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentDevelopment of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus AntibodiesHuman Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment StepIdentification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibodyRemoval of Species Constraints in Antibody DetectionNatural Strain Variation and Antibody Neutralization of Dengue Serotype 3 VirusesThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityStructure of the St. Louis Encephalitis Virus Postfusion Envelope TrimerCrystal Structure of the Japanese Encephalitis Virus Envelope ProteinStructural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-ReactivityThe structural basis for serotype-specific neutralization of dengue virus by a human antibodyIdentification of a New Broadly Cross-reactive Epitope within Domain III of the Duck Tembusu Virus E ProteinProtective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection
P2860
Q24273313-A2D32473-861B-4971-8D4E-0E836151482DQ24288711-E639421E-C7AA-4775-9DB6-2839F181A7FFQ24650772-CE1A4A96-5DCE-431B-AA06-231369DB9EB2Q25708158-13878EA4-5D25-4EF0-A1E6-ACD8DF68CF1DQ26860116-16BCE10F-FF4E-4215-B641-6A106380C5FEQ27315772-FA41F052-E6F2-4587-83CA-AAB37F2D2728Q27470062-9541AAE3-88AA-4FE2-A44F-15ED84A24347Q27477479-2A529FC2-A9E6-4FE0-AE63-03B4EFCCBF30Q27477542-D0F559AF-10BD-4162-BC80-97EE301DE248Q27477646-9BEFD6A2-D1CA-4C2F-87B4-A9A73C1D17FBQ27477648-9B6BE0F3-0BB0-42C1-9825-DE70BD0DB93BQ27477718-DB0970CF-8F48-4470-B93B-7EB42D373B92Q27481450-AFF55C5D-66CD-45E4-A2B8-B5227D32CDDFQ27484362-ACC964CB-13C8-41CD-BE75-45E16BA7DD3DQ27484980-90E2D9A6-F0DA-41AC-B8E0-86907CB970D3Q27485031-D73065D7-3006-4D76-BFEE-ABEFBF3630B3Q27485490-F2BE7BB1-0FD1-4FC6-9BC5-D7028E33D8ACQ27485890-9F3C7B68-79B6-4024-BC6A-6C0CD99032CBQ27486109-89AEAF3D-F013-44B5-BEBB-1794450BA6FFQ27486409-81F02CEF-05E6-4868-AAB1-8EF92C27045DQ27486916-B047088A-D63A-48C3-AA42-F79E5DDF2763Q27487953-E2A8B996-FEF7-469D-9617-BC3747AC09B8Q27487955-AC3289AA-476E-4EFE-9D80-D843DC280D7BQ27488243-0FB6F8B5-B09E-4A45-B312-3F8D5EA6A77CQ27488337-61EC0892-24D1-4113-941E-E19B35A35C8DQ27488364-ABFEE24E-A2B4-4D26-BD25-4F6495EFAB3DQ27488387-050BA17D-33D6-4FE5-B501-E3E353D5F659Q27488791-9E748591-70CF-4B85-85C3-2F2C6E744C9FQ27489953-6011C5F8-DCB9-43B4-BC43-B88216DBF94EQ27490283-70DEBB7D-0CED-4FCC-93A6-8CE9DF9A2388Q27490842-375315EE-3093-4343-8B3B-6B69B74A4A10Q27491299-EF53C7C4-DF85-45FC-8DC2-DFCEA7315DD7Q27491317-507D6A0E-DB4B-4633-9ABA-FC4FEC06C371Q27654848-107F5311-BF0C-4068-AC63-EE7A35703D1AQ27674868-234A0BEB-9035-43FB-92CE-A7458414EB1DQ27676100-C899A52F-F371-486B-B8A8-6988277751E5Q27678419-50E85937-A764-4D7B-A9EC-CA1CEB1BB3A4Q27681306-E2A399DE-1796-4C03-8E57-8A3DC310AC9CQ27927982-213E0459-4020-49D7-AC30-D63E21FCAFE2Q28119679-5578AF6B-98C3-4511-BDB1-7953934E42DB
P2860
Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@ast
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en-gb
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@nl
type
label
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@ast
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en-gb
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@nl
altLabel
Localization and characterizat ...... rotein cross-reactive epitopes
@en
prefLabel
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@ast
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en-gb
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@nl
P2860
P3181
P1433
P1476
Localization and Characterizat ...... rotein Cross-Reactive Epitopes
@en
P2093
G.-J. J. Chang
W. D. Crill
P2860
P304
13975-13986
P3181
P356
10.1128/JVI.78.24.13975-13986.2004
P407
P5008
P577
2004-11-24T00:00:00Z